Attached files
| file | filename |
|---|---|
| EX-32.1 - EX-32.1 - Aeglea BioTherapeutics, Inc. | agle-ex321_11.htm |
| EX-31.1 - EX-31.1 - Aeglea BioTherapeutics, Inc. | agle-ex311_9.htm |
| EX-23.1 - EX-23.1 - Aeglea BioTherapeutics, Inc. | agle-ex231_10.htm |
| EX-4.5 - EX-4.5 - Aeglea BioTherapeutics, Inc. | agle-ex45_723.htm |
| EX-4.3 - EX-4.3 - Aeglea BioTherapeutics, Inc. | agle-ex43_722.htm |
| 10-K - 10-K - Aeglea BioTherapeutics, Inc. | agle-10k_20201231.htm |
Exhibit 21.1
Subsidiaries of Aeglea BioTherapeutics, Inc.
|
|
|
|
|
Name of Subsidiary |
|
Jurisdiction |
|
Aeglea Development Company, Inc. |
|
Delaware |
|
|
|
|
|
AERase, Inc. |
|
Delaware |
|
|
|
|
|
AECase, Inc. |
|
Delaware |
|
|
|
|
|
AEMase, Inc. |
|
Delaware |
|
|
|
|
|
AE4ase, Inc. |
|
Delaware |
|
|
|
|
|
AE5ase, Inc. |
|
Delaware |
|
|
|
|
|
AE6ase, Inc. |
|
Delaware |
|
|
|
|
|
Aeglea Biotherapeutics UK Limited |
|
England and Wales |
|
Aeglea Ireland Limited |
|
Ireland |
|
|